Pilates Effects on Forward Head Posture: a Clinical Trial

March 16, 2025 updated by: yusuf yaşasın, Bahçeşehir University

The Impact of Pilates Exercises on Pain, Posture, Range of Motion, Quality of Life, and Body Composition in Participants with Forward Head Posture: a Randomized Controlled Trial

This study aims to investigate and compare the effects of 8-week Pilates exercises and cervical stabilization exercises on pain, posture, range of motion, quality of life, and body composition in individuals with forward head posture (FHP). FHP is a common postural disorder characterized by the anterior displacement of the head relative to the cervical spine. This condition can lead to neck pain, muscle tension, and limited movement.

The study will include participants aged 18-50 years with FHP. Participants will be randomly assigned to one of two groups: the Pilates group or the cervical stabilization exercise group. The Pilates group will participate in Pilates exercises twice a week for 8 weeks under the supervision of a physiotherapist. The cervical stabilization exercise group will perform cervical stabilization exercises at home for the same duration.

The primary objective of this study is to compare the effects of Pilates and cervical stabilization exercises on FHP. Participants' posture, neck pain, range of motion, quality of life, and body composition will be measured before and after the 8-week intervention. These measurements will be used to evaluate and compare the effectiveness of the two exercise methods on FHP.

This study seeks to investigate the effectiveness of Pilates in the treatment of FHP and contribute to the scientific literature in this field. The findings may help determine the most appropriate exercise method for individuals with FHP.

Study Overview

Detailed Description

This study will be designed as an 8-week randomized controlled trial (RCT) to compare the effects of Pilates and cervical stabilization exercises (CSE) on forward head posture (FHP) in adult participants. Based on the understanding that proper posture is essential to maintain musculoskeletal balance and minimize excessive mechanical strain, the study will address the increasing prevalence of FHP-a problem exacerbated by sedentary lifestyles, prolonged screen use, and occupational demands. In FHP, the head is displaced forward relative to the cervical spine, disrupting the natural spinal curvature, which can lead to neck pain and altered muscle activation patterns.

The trial will be conducted in a controlled clinical setting at a physiotherapy center in Antalya, Turkey, in accordance with CONSORT 2010 guidelines. Robust randomization and blinded outcome assessments will be employed to ensure methodological rigor, and quality assurance protocols-such as regular equipment calibration and data audits-will be implemented to maintain data integrity.

Participants randomized to the Pilates intervention will participate in supervised sessions twice per week, each lasting 60 minutes, consisting of a 10-minute warm-up, a graduated main exercise phase, and a 10-minute cool-down. During the first four weeks, sessions will emphasize mat-based exercises focusing on core engagement, controlled breathing, and alignment. Beginning in Week 2, additional equipment (e.g., Pilates balls and 1-kg dumbbells) will be introduced, with resistance bands incorporated from Week 4 and further modified in Week 6 to progressively challenge participants. The control group will perform a daily CSE regimen (including chin tuck, cervical extension, shoulder elevation, and scapular retraction) structured into two sets designed to support neuromuscular control and postural stability. Both groups will receive ergonomic guidelines for daily posture management.

Data collection will be managed by trained physiotherapists who will adhere to strict protocols and perform regular device calibrations. Data analysis will be conducted using IBM SPSS Statistics (v29.0), employing appropriate statistical tests and calculating effect sizes, with a 95% confidence interval (p < 0.05) determining statistical significance. A comprehensive quality assurance plan-including regular audits, predefined data validation rules, and a maintained data dictionary-will further ensure the robustness and reliability of the findings.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alanya
      • Antalya, Alanya, Turkey, 07460
        • Physiolab Physiotherapy Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults aged 18-50 years.
  • Craniovertebral angle (CVA) < 54°
  • Sedentary lifestyle

Exclusion Criteria:

  • History of spinal surgery (cervical/thoracic/lumbar) or neurological disorders.
  • Acute or severe cervical trauma (e.g., fractures, whiplash injuries).
  • Spinal deformities (e.g., scoliosis, kyphosis).
  • Recent physiotherapy/manual therapy (within the past 6 months).
  • Regular use of analgesics, muscle relaxants, or steroids.
  • Active participation in regular exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pilates Exercise Group
Participants in this group performed Pilates exercises twice a week for 8 weeks. The exercises included mat and equipment-based exercises, focusing on core stabilization, breathing control, and postural alignment. Exercise difficulty was progressively increased throughout the intervention period.
Participants in this group performed Pilates exercises twice a week for 8 weeks. The exercises included mat and equipment-based exercises, focusing on core stabilization, breathing control, and postural alignment. Exercise difficulty was progressively increased throughout the intervention period.
Active Comparator: Cervical Stabilization Exercise Group
Participants in this group performed cervical stabilization exercises at home twice daily for 8 weeks.
Participants in this group performed cervical stabilization exercises at home twice daily for 8 weeks. The exercises included chin tucks, cervical extensions, shoulder elevations, and scapular retractions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Craniovertebral Angle (CVA)
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8).
The craniovertebral angle (CVA), a key metric and a widely used measure for assessing forward head posture (FHP), will be evaluated using standardized digital photogrammetry. Lateral photographs will be captured using a Fujifilm XT-3 mirrorless camera equipped with a 35mm lens. The CVA will be calculated as the angle between a line connecting the tragus and C7 markers and a horizontal reference line parallel to the floor. Higher CVA values will indicate a less severe forward head posture, reflecting better postural alignment.
Baseline (week 0) and after the 8-week intervention (week 8).
Neck Pain Intensity
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8).
Neck pain intensity will be assessed using the Visual Analog Scale (VAS), a 10 cm line ranging from 0 (no pain) to 10 (unbearable/most severe pain). Participants will be instructed to rate their neck-specific discomfort on this scale. Lower scores will indicate less pain, while higher scores will indicate more severe pain.
Baseline (week 0) and after the 8-week intervention (week 8).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Posture
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
Posture will be assessed using the New York Posture Rating Scale (NYPRS). This method, also known as New York Posture Analysis Method (NYPAY), scores 13 body regions (head, neck, shoulders, back, waist, abdomen, pelvis, and feet) from posterior and lateral views. For each region, postural deviations will be scored observationally: 5 points for good posture, 3 points for moderately impaired posture, and 1 point for severely impaired posture. The body regions assessed include: head, neck, shoulders, back, waist, abdomen, pelvis, and feet. Total scores will be calculated by summing the scores across all 13 regions, resulting in a range from 13 (worst possible posture) to 65 (best possible posture). For interpretation, total NYPRS scores are categorized as follows: ≥45 points "very good", 40-44 points "good", 30-39 points "medium", 20-29 points "weak", and ≤19 points "bad" posture.. Therefore, higher total scores will indicate better overall posture.
Baseline (week 0) and after the 8-week intervention (week 8)
Cervical Range of Motion (ROM)
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
Cervical range of motion (ROM), encompassing flexion, extension, lateral flexion, and rotation, will be measured using a standard universal goniometer. Maximum ROM angles will be recorded in degrees. For cervical ROM, higher values will indicate a greater range of motion, which is generally considered a better outcome.
Baseline (week 0) and after the 8-week intervention (week 8)
SF-36 Quality of Life Questionnaire
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
Quality of life will be assessed using the Short Form-36 (SF-36) questionnairea comprehensive questionnaire evaluating different aspects of quality of life (physical, mental, social, etc.). This 36-item scale evaluates participants' health status over the past 4 weeks. The SF-36 includes eight subscales: physical functioning, role-physical, role-emotional, energy/vitality, mental health, social functioning, pain, and general health perceptions. Each subscale yields a score ranging from 0 to 100, where higher scores will indicate better quality of life in the respective domain.
Baseline (week 0) and after the 8-week intervention (week 8)
Body Mass Index (BMI)
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
Body mass index (BMI) is a measure of body fat based on height and weight. It is calculated as weight in kilograms divided by height in meters squared (kg/m²). Weight will be measured using a calibrated digital scale, and height will be measured using a stadiometer.
Baseline (week 0) and after the 8-week intervention (week 8)
Waist-to-hip ratio
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
The waist-to-hip ratio is calculated by dividing the waist circumference by the hip circumference (both measured in centimeters).
Baseline (week 0) and after the 8-week intervention (week 8)
Waist circumference
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
Waist circumference is measured in centimeters at the level of the narrowest point between the lower rib and the iliac crest using a standard measuring tape. Three measurements will be taken at this point, and the average of these measurements will be recorded.
Baseline (week 0) and after the 8-week intervention (week 8)
Hip circumference
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
Hip circumference is measured in centimeters at the level of the widest portion of the buttocks using a standard measuring tape. Three measurements will be taken at this point, and the average of these measurements will be recorded.
Baseline (week 0) and after the 8-week intervention (week 8)
Chest circumference
Time Frame: Baseline (week 0) and after the 8-week intervention (week 8)
Chest circumference is measured in centimeters at the level of the nipples using a standard measuring tape during normal breathing. Three measurements will be taken at this level, and the average of these measurements will be recorded.
Baseline (week 0) and after the 8-week intervention (week 8)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 25, 2023

Primary Completion (Actual)

May 18, 2023

Study Completion (Actual)

May 18, 2023

Study Registration Dates

First Submitted

March 5, 2025

First Submitted That Met QC Criteria

March 16, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 16, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All anonymized individual participant data (IPD) collected in this study, including demographic details, clinical measurements (CVA, pain scores, cervical ROM), SF-36 quality-of-life outcomes, and body composition data, will be shared upon reasonable request. Data will exclude raw imaging files, identifiable personal information, and non-anonymized records. Access requires submission of a scientifically valid proposal, a signed data access agreement, and compliance with ethical guidelines. Shared data will be deposited in a secure, open-access repository (e.g., Zenodo) with a DOI assigned for long-term availability. Data will remain accessible for at least 5 years post-publication. Requests will be reviewed by an independent committee to ensure alignment with research ethics and participant privacy protections (GDPR/Helsinki Declaration compliant).

IPD Sharing Time Frame

IPD and supporting information will be available starting March 5, 2025 and will remain accessible for 5 years.

IPD Sharing Access Criteria

Anonymized individual participant data (IPD) and supporting documents (study protocol, statistical analysis plan, informed consent form) will be provided upon request to researchers affiliated with academic institutions who have collaborated with the institution where the study was conducted and have signed a data use agreement. To access the data, researchers must submit their research proposals and request forms directly to yusufyasasin@gmail.com. The data will be stored on the secure server of the institution where the study was conducted. Access requests will be approved by the ethics committee of the institution where the study was conducted.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe